Infection Control Market Forecasts to 2030 - Global Analysis By Product & Service, By End User and By Geography

According to Stratistics MRC, the Global Infection Control Market is accounted for $237.96 billion in 2023 and is expected to reach $426.70 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Infection control refers to a set of practices and measures aimed at preventing the spread of infectious agents, such as bacteria, viruses, fungi, and parasites, within healthcare settings, community environments, or other contexts where the transmission of infections can occur. The primary goals of infection control are to protect individuals from acquiring infections and to prevent the spread of infections from one person to another.

According to the statistics published by WHO, Acute Respiratory Diseases (ARDs) is one of the major causes of high mortality rates globally. Approximately 4.0 million deaths occur every year due to ARDs.

Market Dynamics:

Driver:

Rising prevalence of hospital-acquired infections (HAIs)

Every year, unsafe and inadequate medical care results in the injuries or deaths of millions of patients. Numerous medical procedures and risks associated with healthcare significantly increase the burden of harm from inadequate care. According to the World Health Organization, complications from unsafe surgical procedures can affect up to 25% of patients. 7 to 10 out of every 100 patients in hospitals in high-income and low- and middle-income countries suffer from healthcare-associated infections. The Centers for Disease Control (CDC) also note that HAIs are thought to be responsible for 99,000 fatalities annually in addition to 1.7 million infections. Hospital infections are increasing, which has fueled demand for infection control products and accelerated market expansion.

Restraint:

Negatively effects of chemical disinfectants

The majority of chemical disinfectants currently available on the market have toxic properties. Misuse of disinfectants can put patients exposed to them and the environment in danger. The Environmental Protection Agency (EPA), which classifies these disinfection products as pesticides, requires registration for all disinfectants sold in the US. Moreover, manufacturers are currently under pressure to develop cleaner, more environmentally friendly disinfectants that are less damaging to people's eyes, like pH-neutral quaternary, butyl-free, and disinfectants based on hydrogen peroxide. Such factors impede market expansion.

Opportunity:

Growing expansion in emerging markets

The market for infection control is predicted to grow as a result of untapped opportunities, improved infrastructure for the healthcare sector, an increase in the number of pharmaceutical and medical device companies, and rising consumer demand for infection control products. The healthcare sector is expanding in emerging economies as a result of the rise in demand for more sophisticated manufacturing systems and significant government investments to upgrade healthcare infrastructure. Asian countries have experienced growth in the pharmaceutical research and medical device industries as a result of the abundance of resources available. Combining all these elements is anticipated to present a variety of opportunities for market expansion during the forecast period.

Threat:

Healthcare budget constraints and compliance challenges

Healthcare budget constraints and cost-conscious practices may limit investments in advanced infection control technologies. Market saturation and intense competition among suppliers could exert downward pressure on prices, potentially impacting profitability. Additionally, regulatory changes and compliance challenges in different regions also pose a threat, requiring companies to navigate complex standards, which further restrains market growth.

COVID-19 Impact:

The COVID-19 pandemic has profoundly impacted infection control practices worldwide. It has heightened awareness about the importance of stringent infection control measures, leading to increased demand for personal protective equipment (PPE), sanitation products, and healthcare disinfectants. Hospitals and healthcare facilities have implemented more rigorous protocols to prevent disease transmission. Additionally, the pandemic has accelerated the development and adoption of novel infection control technologies and strategies. It serves as a stark reminder of the need for robust preparedness and investment in infection control in healthcare and public spaces, further reshaping the industry to meet evolving challenges during this period.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment contributes the most to the market and is anticipated to have the largest market share during the forecast period. Hospitals contain healthcare facilities with trained medical personnel, nursing personnel, and specialized equipment. Increased government initiatives to ensure high levels of infection prevention, an increase in hospitals with cutting-edge infection control techniques, an increase in the number of surgical procedures carried out in hospitals, and an increase in the number of elderly people living alone are all factors contributing to the segment's expansion.

The sterilization products and services segment is expected to have the highest CAGR during the forecast period

During the anticipated timeframe, the segment for sterilization products and services is predicted to have the highest CAGR. Antibiotics might not be able to stop such a widespread attack, so sterilization is crucial to preventing infectious diseases from spreading throughout hospitals or other healthcare facilities. Infectious diseases claim the lives of 17 million people each year, according to the World Health Organization (WHO), which estimates that at least 30 new diseases have emerged in the last 20 years. Over the course of the forecast period, it is also anticipated that rising surgical rates, an increase in the prevalence of infectious diseases, and expansion in the healthcare sector will spur market expansion.

Region with largest share:

During the forecast period, North America is anticipated to maintain its leadership in the infection control market. Some important factors influencing market growth include the presence of major market players in the region, a well-developed healthcare infrastructure, and the widespread use of infection control technologies. The larger share seized by this region is thought to be due to a consistent number of strategic collaborations adopted by key market players to expand their product portfolio and infection control capabilities. Additionally, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's dominant market share.

Region with highest CAGR:

Asia Pacific region is expected to exhibit the highest CAGR throughout the forecast period owing to the growing presence of outsourcing organizations, growing healthcare expenditure, and the unprecedented evolution of healthcare standards and infrastructure across this region. The presence of various voluntary and government organizations focused on improving infection control standards is also one of the significant factors contributing to the growth of the Asia-Pacific region. Additionally, the increasing trend of outsourcing by established market players in developed economies to companies in the Asia-Pacific region also serves as a key growth-impelling factor for the market.

Key players in the market:

Some of the key players in Infection Control Market include: Ecolab Inc., Fortive Corporation (Advanced Sterilization Products), Genitge Ab, Matachana Group, Miele Group. (Steelco), MMM Group, Sotera Health Inc and Steris PLC.

Key Developments:

In September 2023, 3M reported that both the split-off exchange offer for 3M common stock and the closure of the merger of Garden SpinCo Corporation ("SpinCo"), the 3M subsidiary owning the food safety business, with a subsidiary of Neogen Corporation had been completed ("Neogen").

In June 2023, Social care nurses in Scotland can now access the latest infection prevention and control (IPC) guidance in their pocket thanks to a new app launched this week. It was developed in partnership between the Scottish Social Services Council (SSSC), NHS Education for Scotland (NES) and the Digital Health & Care Innovation Centre (DHI).

In May 2023, Getinge announced an agreement to acquire High Purity New England, Inc., a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. Getinge has paid approximately SEK 1,330 M (USD 120 M) in cash on closing, on a cash and debt free basis for 100 % of the shares. In addition, a maximum earn out of approximately SEK 1,880 M (USD 170 M) can be paid out during 2024 - 2026 if agreed net revenue performance milestones are achieved in 2023 - 2025.

Product & Services Covered:

• Sterilization Products and Services
• Cleaning and Disinfection Products
• Protective Barriers
• Endoscope Reprocessing Products
• Other Infection Control Products

End Users Covered:

• Hospitals
• Clinics
• Food Industry
• Laboratories
• Medical Device Companies
• Pharmaceutical Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances